BLACK DIAMOND THERAPEUTICS - ANNOUNCES POSITIVE PHASE 2 SILEVERTINIB RESULTS AND FDA FEEDBACK FOR 1L EGFR-NCM NSCLC - SEC FILING

Reuters · 5d ago

Please log in to view news